Izrael - héber - Ministry of Health

teva israel ltd - pemetrexed as diacid monohydrate - תרכיז להכנת תמיסה לאינפוזיה - pemetrexed as diacid monohydrate 25 mg / 1 ml - pemetrexed

Izrael - héber - Ministry of Health

medison pharma ltd - cx-024414 mrna - cx-024414 mrna 1.26 mg/vial - covid-19 vaccines

Izrael - héber - Ministry of Health

sanofi israel ltd - insulin glulisine - תמיסה להזרקה - insulin glulisine 100 u/ml - insulin glulisine - insulin glulisine - treatment of adults, adolescents and children, 6 years or older with diabetes mellitus, where treatment with insulin is required.

Izrael - héber - Ministry of Health

meditrend marketing (2004) ltd, israel - benzoxonium chloride; chlorhexidine as gluconate; vitamin a palmitate - משחה - vitamin a palmitate 0.2 %w/w; benzoxonium chloride 0.1 %w/w; chlorhexidine as gluconate 0.5 %w/w - chlorhexidine, combinations - chlorhexidine, combinations - disinfection of minor superficial wounds, minor burns (first degree).

Izrael - héber - Ministry of Health

pfizer pharmaceuticals israel ltd - neisseria meningitidis group a polysaccharide; neisseria meningitidis group c polysaccharide; neisseria meningitidis group w - 135 polysaccharide; neisseria meningitidis group y polysaccharide - אבקה וממס להכנת תמיסה להזרקה - neisseria meningitidis group y polysaccharide 5 mcg; neisseria meningitidis group w - 135 polysaccharide 5 mcg; neisseria meningitidis group c polysaccharide 5 mcg; neisseria meningitidis group a polysaccharide 5 mcg - other meningococcal monovalent purified polysaccharides antigen - other meningococcal monovalent purified polysaccharides antigen - nimenrix is indicated for active immunisation of individuals from the age of 12 months and above against invasive meningococcal diseases caused by neisseria meningitidis group a, c, w-135 and y.

Izrael - héber - Ministry of Health

pfizer pharmaceuticals israel ltd - etanercept - אבקה וממס להכנת תמיסה להזרקה - etanercept 25 mg/vial - etanercept - etanercept - * rheumatoid arthritis:enbrel is indicated for the treatment of active rhematoid arthritis in adults when the response to disease-modifying antirheumatic drugs (dmards) including methotrexate (unless contraindicated) has been inadequate.. enbrel can be used in combination with methotrexate in patients who do not respond adequately to methotrexate alone. reducing signs and symptoms and inhibiting the progression of structural damage in patients with moderately to severely active rheumatoid arthritis.enbrel, alone or in combination with methotrexate, has been shown to reduce the rate of progression of joint damage as measured by x-ray and to improve physical function.* polyarticular juvenile idiopathic arthritis: treatment of active polyarticular juvenile idiopathic arthritis in children and adolescents from the age of 2 years who have had an inadequate response to, or who have proved intolerant of, methotrexate. enbrel has not been studied in children aged less than 2 years.* psoriatic arthritistreatment of ac

Izrael - héber - Ministry of Health

megapharm ltd - iloperidone - טבליה - iloperidone 1 mg - iloperidone - iloperidone - fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.

Izrael - héber - Ministry of Health

megapharm ltd - iloperidone - טבליה - iloperidone 2 mg - iloperidone - iloperidone - fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.

Izrael - héber - Ministry of Health

megapharm ltd - iloperidone - טבליה - iloperidone 4 mg - iloperidone - iloperidone - fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.

Izrael - héber - Ministry of Health

megapharm ltd - iloperidone - טבליה - iloperidone 6 mg - iloperidone - iloperidone - fanapt is an atypical antipsychotic agent indicated for the treatment of schizophrenia in adults.